Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-021-00612-9, published online 19 February 2021
The authors apologize that in Fig. 5d, the western blotting bands of HCT116 cells treated with 2DG (5 mM) and different concentrations of lovastatin were the same as cells treated with lovastatin (10 μM) and different concentrations of 2DG, which was misplaced inadvertently. The correct figure is reproduced and presented. The conclusions are not affected by this correction. We sincerely apologize for our mistakes and any inconvenience this might have caused.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41401-021-00612-9.
Rights and permissions
About this article
Cite this article
Huang, Xm., Huang, Jj., Du, Jj. et al. Author Correction: Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin. Acta Pharmacol Sin 43, 1881 (2022). https://doi.org/10.1038/s41401-021-00834-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-021-00834-x